Michael Gillin
Overview
Explore the profile of Michael Gillin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
58
Citations
1416
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Geng H, Giaddui T, Cheng C, Zhong H, Ryu S, Liao Z, et al.
J Appl Clin Med Phys
. 2021 Aug;
22(10):329-337.
PMID: 34432946
Background And Purpose: The efficacy of clinical trials and the outcome of patient treatment are dependent on the quality assurance (QA) of radiation therapy (RT) plans. There are two widely...
2.
Liao L, Lim G, Li Y, Yu J, Sahoo N, Li H, et al.
Int J Part Ther
. 2019 Nov;
3(2):305-311.
PMID: 31772982
We have developed a robust optimization approach for intensity modulated proton therapy treatment plans with multi-isocenter large fields. The method creates a low-gradient field dose in the junction regions to...
3.
Pugh T, Choi S, Nogueras-Gonzalaez G, Nguyen Q, Mahmood U, Frank S, et al.
Int J Part Ther
. 2019 Nov;
3(1):27-36.
PMID: 31772973
Purpose: To report prostate cancer outcomes, toxicity, and quality of life (QOL) in men treated with proton beam therapy (PBT). Patients And Methods: Patients were enrolled in a prospective trial....
4.
Yang Z, Li H, Li Y, Li Y, Chang Y, Li Q, et al.
Radiat Oncol
. 2019 Jul;
14(1):129.
PMID: 31324257
Purpose: To assess the worst-case robust optimization IMPT plans with setup and range uncertainties and to test the hypothesis that the worst-case robust optimization strategies could cover most possible setup...
5.
Wang L, Han S, Zhu J, Wang X, Li Y, Wang Z, et al.
Head Neck
. 2018 Dec;
41(1):46-55.
PMID: 30561022
Background: Photon (X-ray) radiotherapy (XRT) kills cells via DNA damage, however, how proton radiotherapy (PRT) causes cell death in head and neck squamous cell carcinoma (HNSCC) is unclear. We investigated...
6.
Sahoo N, Poenisch F, Zhang X, Li Y, Lii M, Li H, et al.
Med Dosim
. 2018 May;
43(2):184-194.
PMID: 29753334
The capabilities of the Eclipse treatment planning system (TPS) (Varian Medical Systems, Palo Alto, CA) for proton therapy treatment planning are described. Various steps involved in the planning process to...
7.
Ho J, Nguyen Q, Li H, Allen P, Zhang X, Liao Z, et al.
Pract Radiat Oncol
. 2017 Sep;
8(1):58-65.
PMID: 28867546
Purpose: Reirradiation of thoracic malignancies is a treatment challenge, with concerns for toxicity and the inability to deliver definitive doses. Intensity modulated proton therapy (IMPT) may allow safe delivery of...
8.
Chang J, Zhang W, Komaki R, Choi N, Chan S, Gomez D, et al.
Radiother Oncol
. 2017 Feb;
122(2):274-280.
PMID: 28139305
Purpose: The aim of this phase I/II study was to assess the long-term clinical benefits and toxicities of proton beam therapy for medically inoperable early-stage non-small cell lung cancer (NSCLC)....
9.
Wang L, Wang X, Li Y, Han S, Zhu J, Wang X, et al.
Head Neck
. 2017 Jan;
39(4):708-715.
PMID: 28039958
Background: Human papillomavirus (HPV)-positive oropharyngeal carcinomas response better to X-ray therapy (XRT) than HPV-negative disease. Whether HPV status influences the sensitivity of head and neck cancer cells to proton therapy...
10.
Giaddui T, Chen W, Yu J, Lin L, Simone 2nd C, Yuan L, et al.
Radiat Oncol
. 2016 May;
11:66.
PMID: 27142674
Background: To establish the feasibility of the dosimetric compliance criteria of the RTOG 1308 trial through testing against Intensity Modulation Radiation Therapy (IMRT) and Passive Scattering Proton Therapy (PSPT) plans....